Anna M. Burgner, MD
Assistant Professor of Medicine
Division
Nephrology and Hypertension
Assistant Professor of Medicine
Professional Bio
Anna Burgner, MD, is an Assistant Professor of Medicine in the Division of Nephrology and Hypertension within the Department of Medicine at Vanderbilt University Medical Center.
She is currently the Associate Program Director of the Vanderbilt Nephrology Fellowship Program. She completed a Master of Education in the Health Professions with a focus on nephrology education improvement and curriculum development. She directs the Vanderbilt medical students’ course in interprofessional education, and the nephrology consult elective.
Dr. Burgner directs many of the Vanderbilt nephrology division’s conferences, including Renal Grand Rounds, Dialysis Access Conference, Nephrology Clinical Conference, and Nephrology Journal Club. She also chairs the nephrology fellowship education committee.
Dr. Burgner is the associate director of the Nephrology Clinical Trials Center where she has been PI or co-PI on both NIH and industry sponsored phase 2 and phase 3 clinical studies including SPRINT, DAPA-CKD, FIGARO, and FIDELIO trials. She has particular interest in clinical trials in nephrology regenerative medicine, diabetic nephropathy, polycystic kidney disease, and hypertension in chronic kidney disease.
She is currently the Associate Program Director of the Vanderbilt Nephrology Fellowship Program. She completed a Master of Education in the Health Professions with a focus on nephrology education improvement and curriculum development. She directs the Vanderbilt medical students’ course in interprofessional education, and the nephrology consult elective.
Dr. Burgner directs many of the Vanderbilt nephrology division’s conferences, including Renal Grand Rounds, Dialysis Access Conference, Nephrology Clinical Conference, and Nephrology Journal Club. She also chairs the nephrology fellowship education committee.
Dr. Burgner is the associate director of the Nephrology Clinical Trials Center where she has been PI or co-PI on both NIH and industry sponsored phase 2 and phase 3 clinical studies including SPRINT, DAPA-CKD, FIGARO, and FIDELIO trials. She has particular interest in clinical trials in nephrology regenerative medicine, diabetic nephropathy, polycystic kidney disease, and hypertension in chronic kidney disease.
Education
MD - Indiana University - 2007
Residency - Categorical Internal Medicine - Vanderbilt University - 2010
Fellowship - Clinical Nephrology - Vanderbilt University - 2013
Fellowship - Chief Nephrology Fellow - Vanderbilt University - 2013
Master - Education in the Health Professions - Johns Hopkins University - 2015